Journal Article (382)
2003
Journal Article
362 (9388), pp. 971 - 982 (2003)
Polymyositis and dermatomyositis. Lancet
Journal Article
112 (4), pp. 544 - 553 (2003)
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. Journal of Clinical Investigation
Journal Article
163 (4), pp. 1215 - 1226 (2003)
T-cell-mediated autoimmunity - Novel techniques to characterize autoreactive T-cell receptors. American Journal of Pathology
Journal Article
126, p. E1 - E1 (2003)
Glatiramer acetate treatment in Devic's neuromyelitis optica - Reply. Brain
Journal Article
10 (7), pp. 535 - 540 (2003)
Crystal structure of the apoptosis-inducing human granzyme A dimer. Nature Structural Biology
Journal Article
100 (7), pp. 4090 - 4095 (2003)
Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
126, pp. 2 - 4 (2003)
Hunting (auto)immune T cells in neuroimmunological diseases. Brain
Journal Article
10, pp. 103 - 105 (2003)
The prospects for neuroprotection in MS. International MS Journal
Journal Article
23, pp. 121 - 131 (2003)
Basic principles of immunotherapy for neurologic diseases. Seminars in Neurology
Journal Article
37 (2), pp. 111 - 120 (2003)
Complete physical map and gene content of the human NFI tumor suppressor region in human and mouse. Genes Chromosomes & Cancer
Journal Article
40 (10), e116 (2003)
Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. Journal of Medical Genetics
Journal Article
10 (1), pp. 2 - 4 (2003)
Neurotrophic factors protect myelin from attack. International MS Journal
Journal Article
53 (3), pp. 292 - 304 (2003)
Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Annals of Neurology
Journal Article
37 (5), pp. 751 - 764 (2003)
Neuronal or glial progeny: Regional differences in radial glia fate. Neuron
Journal Article
139 (1-2), pp. 1 - 8 (2003)
Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. Journal of Neuroimmunology
Journal Article
350 (3), pp. 165 - 168 (2003)
Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neuroscience Letters
Journal Article
40 (7), pp. 520 - 525 (2003)
Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. Journal of Medical Genetics
Journal Article
61 (8), pp. 1159 - 1161 (2003)
Neuropsychiatric findings in anti-Ma2 positive paraneoplastic limbic encephalitis. Neurology
Journal Article
163 (6), pp. 2179 - 2184 (2003)
Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. American Journal of Pathology
Journal Article
74, p. 282 - 282 (2003)
Anti-titin antibodies are not associatd with a specific thymoma histology. Journal of Neurology, Neurosurgery and Psychiatry
Journal Article
349 (2), pp. 185 - 186 (2003)
Molecular mimicry in multiple sclerosis. New England Journal of Medicine
Journal Article
126, pp. 176 - 185 (2003)
The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: Implications for myoblast transplnatation and gene therapy. Brain
Journal Article
15 (7), pp. 789 - 796 (2003)
Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo. International Immunology 2002
Journal Article
55 (1), pp. 70 - 81 (2002)
Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scandinavian Journal of Immunology
Journal Article
9 (3), pp. 243 - 251 (2002)
Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. European Journal of Neurology
Journal Article
61 (1), pp. 12 - 22 (2002)
Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. Journal of Neuropathology and Experimental Neurology
Journal Article
24 (3), pp. 212 - 222 (2002)
Synaptic modification in neural circuits: A timely action. Bioessays
Journal Article
265, pp. 141 - 162 (2002)
The role of T cells in brain pathology. Curr Top Microbiol Immunol.
Journal Article
110 (3), pp. 289 - 291 (2002)
Novel de novo mutation of MADH4/SMAD4 in a patient with juvenile polyposis. American Journal of Medical Genetics
Journal Article
162 (1), pp. 307 - 320 (2002)
Mutation of a novel gene results in abnormal development of spermatid flagella, loss of intermale aggression and reduced body fat in mice. Genetics
Journal Article
59 (10), pp. 1507 - 1517 (2002)
A randomised, double-blind, dose-comparison study of weekly interferon ß-1a in relapsing MS. Neurology
Journal Article
123 (1-2), pp. 188 - 192 (2002)
Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients. Journal of Neuroimmunology
Journal Article
249 (11), pp. 1587 - 1592 (2002)
Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis - A pilot study. Journal of Neurology
Journal Article
125, pp. 1425 - 1427 (2002)
Devic's disease: Bridging the gap between laboratory and clinic. Brain
Journal Article
13 (2), pp. 511 - 518 (2002)
Antigen-dependent transgene expression in kidney transplantation: A novel approach using gene-engineered T lymphocytes. Journal of the American Society of Nephrology
Journal Article
277 (52), pp. 50923 - 50933 (2002)
The 2.2-angstrom crystal structure of human pro-granzyme K reveals a rigid zymogen with unusual features. Journal of Biological Chemistry
Journal Article
8 (10), pp. 1075 - 1076 (2002)
Myelin failure in multiple sclerosis: Breaking the spell of Notch. Nature Medicine
Journal Article
249, pp. 1147 - 1149 (2002)
How promising is hematopoetic stem cell transplantation in multiple sclerosis? J Neurol.
Journal Article
99 (13), pp. 8903 - 8908 (2002)
Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
168 (3), pp. 1226 - 1234 (2002)
Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-Regulatory factor 1- dependent domains in the CD95 ligand promoter. Journal of Immunology
Journal Article
128 (3), pp. 395 - 397 (2002)
Immunopathogenesis of multiple sclerosis: MBP and beyond. Clinical and Experimental Immunology
Journal Article
22 (3), pp. 854 - 862 (2002)
Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a Rho-dependent mechanism. The Journal of Neuroscience
Journal Article
51 (2), pp. 215 - 223 (2002)
Inhibition of autoimmune encephalomyelitis by a tetracycline. Annals of Neurology
Journal Article
9 (4), pp. 343 - 347 (2002)
The recognition, diagnosis and management of cerebral vasculitis: A European survey. European Journal of Neurology
Journal Article
125, pp. 75 - 85 (2002)
BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells? Brain
Journal Article
12 (3), pp. 287 - 299 (2002)
MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. Brain Pathology
Journal Article
15 (3), pp. 429 - 434 (2002)
Measles virus-specific T-cell immunity in rodent models. Viral Immunology
Journal Article
186 (Suppl. 2), pp. S140 - S144 (2002)
Immune protection of the brain - Efficient and delicate. The Journal of Infectious Diseases
Journal Article
420 (6911), pp. 39 - 40 (2002)
Tackling multiple sclerosis. Nature
Journal Article
16 (3), pp. 183 - 200 (2002)
Therapeutic approaches in multiple sclerosis - Lessons from failed and interrupted treatment trials. Biodrugs